1. Home
  2. PACB vs DSU Comparison

PACB vs DSU Comparison

Compare PACB & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • DSU
  • Stock Information
  • Founded
  • PACB 2000
  • DSU 1998
  • Country
  • PACB United States
  • DSU United States
  • Employees
  • PACB N/A
  • DSU N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • DSU Finance Companies
  • Sector
  • PACB Industrials
  • DSU Finance
  • Exchange
  • PACB Nasdaq
  • DSU Nasdaq
  • Market Cap
  • PACB 452.1M
  • DSU 511.0M
  • IPO Year
  • PACB 2010
  • DSU N/A
  • Fundamental
  • Price
  • PACB $1.85
  • DSU $10.85
  • Analyst Decision
  • PACB Buy
  • DSU
  • Analyst Count
  • PACB 15
  • DSU 0
  • Target Price
  • PACB $2.92
  • DSU N/A
  • AVG Volume (30 Days)
  • PACB 12.8M
  • DSU 148.2K
  • Earning Date
  • PACB 11-07-2024
  • DSU 01-01-0001
  • Dividend Yield
  • PACB N/A
  • DSU 10.06%
  • EPS Growth
  • PACB N/A
  • DSU N/A
  • EPS
  • PACB N/A
  • DSU N/A
  • Revenue
  • PACB $173,147,000.00
  • DSU N/A
  • Revenue This Year
  • PACB N/A
  • DSU N/A
  • Revenue Next Year
  • PACB $25.88
  • DSU N/A
  • P/E Ratio
  • PACB N/A
  • DSU N/A
  • Revenue Growth
  • PACB 2.14
  • DSU N/A
  • 52 Week Low
  • PACB $1.16
  • DSU $9.22
  • 52 Week High
  • PACB $10.65
  • DSU $11.40
  • Technical
  • Relative Strength Index (RSI)
  • PACB 42.83
  • DSU 47.97
  • Support Level
  • PACB $1.49
  • DSU $10.75
  • Resistance Level
  • PACB $1.84
  • DSU $10.94
  • Average True Range (ATR)
  • PACB 0.29
  • DSU 0.09
  • MACD
  • PACB -0.07
  • DSU -0.00
  • Stochastic Oscillator
  • PACB 20.73
  • DSU 37.04

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.

Share on Social Networks: